Breast cancer, dietary lignan intake, and CYP17 polymorphism.

被引：0
|
作者：
McCann, SE [1 ]
Moysich, KB [1 ]
Freudenheim, JL [1 ]
Ambrosone, CB [1 ]
Shields, PG [1 ]
机构：
[1] SUNY Buffalo, Buffalo, NY 14214 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2001年 / 153卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
64
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [31] CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
    Spurdle, AB
    Hopper, JL
    Dite, GS
    Chen, XQ
    Cui, JS
    McCredie, MRE
    Giles, GG
    Southey, MC
    Venter, DJ
    Easton, DF
    Chenevix-Trench, G
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (20) : 1674 - 1681
  • [32] MspA1 polymorphism of the CYP17 gene in breast cysts
    Tote Franco Pinotti, Solange Cristina
    Cotrim Guerreiro da Silva, Ismael Dale
    Carvalho, Cristina Valeta
    Pinto Nazario, Afonso Celso
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (06) : 443 - 446
  • [33] The CYP17 MspA1 polymorphism and breast cancer risk:: a meta-analysis
    Ye, Z
    Parry, JM
    MUTAGENESIS, 2002, 17 (02) : 119 - 126
  • [34] CYP17 gene polymorphism in relation to breast cancer risk:: a case-control study
    Einarsdóttir, K
    Rylander-Rudqvist, T
    Humphreys, K
    Ahlberg, S
    Jonasdottir, G
    Weiderpass, E
    Chia, KS
    Ingelman-Sundberg, M
    Persson, I
    Liu, JJ
    Hall, P
    Wedrén, S
    BREAST CANCER RESEARCH, 2005, 7 (06) : R890 - R896
  • [35] CYP17 genetic polymorphism in endometrial cancer: are only steroids involved?
    Berstein, LM
    Imyanitov, EN
    Gamajunova, VB
    Kovalevskij, AJ
    Kuligina, ES
    Belogubova, EV
    Buslov, KG
    Karpova, MB
    Togo, AV
    Volkov, ON
    Kovalenko, IG
    CANCER LETTERS, 2002, 180 (01) : 47 - 53
  • [36] A polymorphism in intron 6 of the CYP17 gene
    Crocitto, LE
    Feigelson, HS
    Yu, MC
    Kolonel, LN
    Henderson, BE
    Coetzee, GA
    CLINICAL GENETICS, 1997, 52 (01) : 68 - 69
  • [37] CYP17 gene polymorphism and prostate cancer susceptibility in a Tunisian population
    Souiden, Yousra
    Mandouani, Manel
    Chaieb, Kamel
    Elkamel, Rafik
    Mandouani, Kacem
    CANCER EPIDEMIOLOGY, 2011, 35 (05) : 480 - 484
  • [38] Association between CYP17 polymorphisms and the development of breast cancer
    Helzlsouer, KJ
    Huang, HY
    Strickland, PT
    Hoffman, S
    Alberg, AJ
    Comstock, GW
    Bell, DA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1998, 7 (10) : 945 - 949
  • [39] Re:: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
    Jernström, H
    Vesprini, D
    Bradlow, HL
    Narod, SA
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (07) : 554 - 555
  • [40] CYP17 polymorphism as a risk factor of tamoxifen-induced hepatic steatosis in breast cancer patients
    Ohnishi, T
    Ogawa, Y
    Saibara, T
    Nishioka, A
    Kariya, S
    Fukumoto, M
    Onishi, S
    Yoshida, S
    ONCOLOGY REPORTS, 2005, 13 (03) : 485 - 489
12345